A Discussion of COPD Surveillance Data

Published Online: Friday, January 17, 2014
Follow Pharmacy_Times:
In this podcast, Earl S. Ford, MD, MPH and David M. Mannino, MD, FCCP, discuss their study of surveillance results for COPD in the United States from 1999 to 2011 with CHEST podcast editor D. Kyle Hogarth, MD, FCCP.

To listen to this podcast, click here.
Related Articles
Cocaine users complaining of chest pain may have abnormal blood flow in the heart’s smallest blood vessels that may not be detected in regular testing, putting these patients at risk for heart complications or death, according to research presented at the American Heart Association’s Scientific Sessions 2014.
In a study of patients with comorbid COPD and metabolic syndrome, elevated triglyceride levels were associated with increased mortality rates.
The FDA is reviewing a regulatory application to add an asthma indication to Boehringer Ingelheim’s chronic obstructive pulmonary disease treatment, tiotropium bromide.
The CHEST Foundation recently launched its Lung Cancer Care: A Team Approach campaign as part of National Lung Cancer Awareness Month. The campaign aims to raise awareness about low treatment rates and the importance of medical specialists working together to provide optimal lung cancer care.
Latest Issues
$auto_registration$